This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. The post Dear FDA: WTF?
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The FDA needs to study what people do when they see a DTC ad. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. DTC ads raise awareness around health conditions.
The FDA’s “accelerated approval” program expedites the evaluation process for new treatments so that patients can have access to them sooner. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5 appeared first on World of DTC Marketing.com.
Patient behavior has changed during the pandemic as Google has shown that more are going online for health information. To portray patients, mindless people who blindly believe DTC TV ads and rush to their doctor to ask for a product are inaccurate. Prescription drugs are not the same as items found in a grocery store.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
A recent draft from the FDA provides valuable insight. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs. What will the future hold for clinical research?
Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. What are other patients saying about it? Is TV the best channel?
The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities. Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations.
(Stat News) Today, a study followed 380 patients being treated at community oncology groups across the U.S. Patients who experience financial hardship during cancer treatment are at higher risk for treatment nonadherence, poor quality of life, and worse survival. after they were diagnosed with metastatic colon cancer. population.
A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists side effects like cancer. DTC marketers need to understand the patient journey a lot better with specific recommendations to silence the “noise” around their medications.
The US Food and Drug Administration (FDA) has granted approval to Bausch + Lomb and Novaliq’s Miebo (perfluorohexyloctane ophthalmic solution) to treat the signs and symptoms of dry eye disease (DED). It is the first and only prescription eye drop to receive FDA approval to treat DED that targets tear evaporation directly.
GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. ” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? ” Uh…no. ” Uh…no.
Patients want quick fixes, and the idea of losing some weight because of a new drug is enticing to them. In response, the company has been providing six-month waivers to some insured patients that will cap the drug’s out-of-pocket costs at $25 a month, though the long-term picture of coverage is still in flux. Click to Tweet.
In a highly regulated industry, choosing the right keywords can determine whether your ads reach healthcare professionals, patients, or caregivers effectively. Understanding how patients and healthcare professionals search for medical information is key. Januvia prescription cost) and non-branded (e.g., A mix of branded (e.g.,
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Strict ad copy guidelines , including FDA-mandated fair balance requirements. However, the landscape isnt simple.
In this article, well dive into key pharma digital marketing strategies that can help pharma brands connect with healthcare professionals (HCPs), patients, and stakeholders effectively. Improve patient engagement with valuable content and resources. Improve patient engagement with valuable content and resources.
The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. AbbVie significantly inflated prices over the past two decades for patients in the U.S. Richard Gonzalez, C.E.O. So how do people who work for AbbVie feel?
That should tell you all you need to know about how bad things are with the FDA and trust in drug approvals. I gained an understanding of the need to follow FDA guidelines and let as many people as possible evaluate the data. For the first time, I am now in fear of FDA drug approvals. Dr. Stephen Hahn, the F.D.A.’s
The US Food and Drug Administration (FDA) has granted priority review for Takeda and HUTCHMED’s new drug application (NDA) for fruquintinib. This 691-patient study was conducted in Europe, the US, Japan and Australia. The FDA has now assigned a prescription drug user fee act action date of 23 November 2023 for the NDA.
A new feature—a sensor that monitors changes in the heart rate for irregularities that can lead to strokes and heart failure—has just been approved by America’s Food and Drug Administration (FDA). The FDA’s stamp of approval for the Fitbit sensor is a big deal. Google is also giving health records another whirl.
The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea’s Hanmi Pharma, which originally developed the drug. The post FDA rejects Spectrum’s lung cancer drug poziotinib appeared first on.
UK-based pharmaceutical giant GSK has announced that the US Food and Drug Administration (FDA) has extended the review period of its new drug application (NDA) for the rare bone cancer drug momelotinib by three months. The FDA’s review will take into account data from the Phase III MOMENTUM trial (NCT04173494).
In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever. A pharmaceutical marketing company does more than run adsit builds connections between your brand, healthcare providers (HCPs), and patients.
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a new drug application (NDA) for its investigational single-tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) to the US Food and Drug Administration (FDA), to treat pulmonary arterial hypertension (PAH).
I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.
Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.
Pharma companies are leveraging AI to: Personalize HCP and patient outreach Optimize digital ad placements Generate high-volume content at scale Predict prescription patterns Analyze social listening data for insights These applications offer the promise of real-time engagement, data-driven decisions, and measurable ROI.
This guide breaks down best practices for PPC campaign optimization , helping pharma marketers reach HCPs and patients without wasting ad spend. Pay-per-click (PPC) advertising allows brands to reach healthcare professionals (HCPs) and patients when they are actively searching for treatment options, drug information, or medical education.
Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC. billion by 2026. This DTC is an embaressment.
The US Food and Drug Administration (FDA) has accepted the supplemental biologics licence application submitted by Bristol Myers Squibb for Reblozyl (luspatercept-aamt) as a first-line treatment of anaemia in adults with lower-risk myelodysplastic syndromes (MDS).
By embracing patient-centric approaches, leveraging digital tools, and staying ahead of trends. The rise of generic drug competitors, stringent regulatory environments, and increasingly empowered patients mean one-size-fits-all approaches no longer work. They are key decision-makers influencing prescription trends.
Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. Pharmaceutical brands like Dupixent, Keytruda, and Ozempic are leading the way with creative digital campaigns that blend patient education with dynamic storytelling.
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. Unlike digital ads that can feel fleeting, traditional campaigns offer lasting impressions, cementing brand authority and patient trust.
If this data isn’t available, the practitioner must limit the prescription to a 7-day supply; Keeps detailed records regarding prescriptions written based on telemedicine encounters. Records can be kept in digital or paper form, and the proposed rule includes specific data points (e.g.,
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. Dr. B was founded in 2021 to connect providers with leftover COVID vaccines to the patients seeking to receive them.
Face-to-face HCP visits dwindled, patients turned to search engines for symptom answers, and telehealth became the norm. Moreover, patients rely heavily on social media, forums, and mobile apps for health information and support. Pharma brands were forced to adapt rapidly. Now, there’s no turning back.
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. For DTC, the model will become one of collaboration with patients as they help them navigate the complex system of American healthcare.
Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Similarly, when patients share their experiences with others, it can drive interest more effectively than brand messaging alone. In pharma, however, the dynamic is more nuanced.
Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. The way HCPs, patients, and caregivers seek information has changed. Animations explaining drug mechanisms attract HCPs and patients alike.
years to win FDA approval, at a median cost of $648 million. Prescription drugs in the United States rank as the most expensive by a long shot with the average cost of medications in the US exceeding the global median price by some 300 percent and have become a hotbed issue to reduce costs. It’s Amazon.
Which platforms provide valuable insights for reaching healthcare professionals (HCPs) and patients? Digital platforms provide a way to streamline outreach efforts, measure campaign performance, and engage with both healthcare professionals and patients.
Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.
The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?
Introduction Social media advertising has become an essential part of pharmaceutical marketing, offering direct access to healthcare professionals (HCPs), patients, and caregivers. Google Ads requires pre-approval for prescription drug promotions, while platforms like TikTok prohibit pharma ads entirely.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content